Floatz logo

Therapeutic Asset Ratings

227 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
ly3023414
Ovarian Cancer
Dana-Farber Cancer InstituteP2CC (46)
Tazemetostat
Metastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer InstituteP1/2CC (46)
Polyiclc
Ovarian Cancer
Dana-Farber Cancer InstituteP1/2CC (44)
Axicabtagene Ciloleucel
Primary Central Nervous System Lymphoma
Dana-Farber Cancer InstituteP1CC (43)
Ciml-Nk Cells
Juvenile Myelomonocytic Leukemia
Dana-Farber Cancer InstituteP1CC (43)
Cyclophosphamide
Anaplastic Oligodendroglioma
Dana-Farber Cancer InstituteP1CC (43)
Cyclophosphamide
Ganglioglioma
Dana-Farber Cancer InstituteP1CC (43)
Cyclophosphamide
Glioma of Brain
Dana-Farber Cancer InstituteP1CC (43)
Cyclophosphamide
Anaplastic Astrocytoma
Dana-Farber Cancer InstituteP1CC (43)
Cyclophosphamide
Brain Glioma
Dana-Farber Cancer InstituteP1CC (43)
Cyclophosphamide
Oligoastrocytoma
Dana-Farber Cancer InstituteP1CC (43)
Cyclophosphamide
Oligodendroglioma
Dana-Farber Cancer InstituteP1CC (43)
Cyclophosphamide
Pilocytic Astrocytoma
Dana-Farber Cancer InstituteP1CC (43)
Cytokine Induced Memory-Like Natural Killer Cells
Myeloproliferative Disorders
Dana-Farber Cancer InstituteP1CC (43)
Cytokine-Induced Memory-Like Natural Killer Cells
Ovarian Clear Cell Adenocarcinoma
Dana-Farber Cancer InstituteP1CC (43)
Cytokine-Induced Memory-Like Natural Killer Cells
Ovarian Endometrioid Adenocarcinoma
Dana-Farber Cancer InstituteP1CC (43)
Epirubicin
Leukemia, B-cell
Dana-Farber Cancer InstituteP1CC (43)
FULVESTRANT
Acute Lymphoblastic Leukemia ALL
Dana-Farber Cancer InstituteP1CC (43)
Mesna
Graft Versus Host Disease
Dana-Farber Cancer InstituteP1CC (43)
Mesna
Myeloid Leukemia
Dana-Farber Cancer InstituteP1CC (43)
Neovax
Lymphoid Leukemia
Dana-Farber Cancer InstituteP1CC (43)
Pembrolizumab
Lymphoid Leukemia
Dana-Farber Cancer InstituteP1CC (43)
Polyiclc
Lymphocytic Leukemia
Dana-Farber Cancer InstituteP1CC (43)
Recombinant Human Interleukin-2
Myelodysplasia
Dana-Farber Cancer InstituteP1CC (43)
Recombinant Human Interleukin-2
Myeloproliferative Disorders
Dana-Farber Cancer InstituteP1CC (43)
Showing 126 to 150 of 227 assets
PreviousPage 6 of 10Next